Connect with us

Spread & Containment

3 “Strong Buy” Biotech Stocks Under $5 With Massive Upside Potential

3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential

Published

on

Is it May 2020 or March 2009? As Wall Street observers traverse the confused economic environment, flashbacks of the Great Recession are coming to mind. Those looking at the glass half empty will point out the bear market that emerged took 18 months to reach the lowest point. However, the optimists are singing a different tune.

Among the bulls is Morgan Stanley’s head of U.S. equity strategy, Michael Wilson. In a recent note to clients, he argues that the current state of the market bears a striking resemblance to March 2009, the period in which the U.S. economy began to recover, with the S&P 500 embarking on what would become the longest bull-market run on record.

“Markets are tracking the Great Financial Crisis period very closely in many ways,” Wilson wrote. To support this claim, the strategist highlights the fact that stocks are bouncing back in a “similar pattern," at the same time the amount of stocks, especially cyclicals, that have exceeded their 200-day moving average is on the rise. This is important as cyclicals usually lead the charge when a market recovery kicks off. Wilson also notes that the equity-risk premium, or the expected earnings yield for the S&P 500 minus the ten-year Treasury yield, looks the same as it did in March 2009, which played into his decision to call a stock-market bottom on March 16 of this year.

Taking Wilson’s views into consideration, risk-tolerant investors are on the hunt for promising names now trading at lower levels, specifically within the biotech space. As it just takes one positive catalyst like strong data or a favorable FDA ruling to send shares skyrocketing, massive returns are on the table. That being said, as the opposite also holds true, these stocks come with their fair share of risk.

Acknowledging the risk involved, we used TipRanks’ database to pinpoint compelling, yet affordable biotech stocks. We found three trading for under $5 that have not only received enough bullish recommendations from analysts to earn a “Strong Buy” consensus rating, but also sport colossal upside potential.

Gamida Cell Ltd. (GMDA)

It has certainly been a rough week for Gamida Cell, which develops therapies that could potentially cure blood cancers and other blood diseases.

On Tuesday, the company unveiled the pricing for its underwritten public offering of 13,333,334 ordinary shares, which landed at $4.50 per share. The fund raise sent shares tumbling, with GMDA walking away from the day’s trading session down 26%. However, the new share price, $4.42, offers an attractive entry point, according to the analyst community.

Weighing in for Oppenheimer, five-star analyst Mark Breidenbach cites recently released positive top-line data from its randomized Phase 3 trial of omidubicel in patients receiving bone marrow transplants as a key component of his bullish thesis. The trial had 125 participants between the ages of 12-65 with high-risk hematologic malignances (AML, CML, MDS, lymphoma), and GMDA’s candidate was studied against standard umbilical cord blood (UCB) grafts.

Not only did omidubicel meet its primary endpoint, but the asset’s failure rate came in at 4% while the UCBs had a failure rate of 12%. After the readout, the company announced that it plans on initiating a rolling BLA submission in the fourth quarter.

Expounding on the implications of the results, Breidenbach stated, “While expecting to see full results are at a medical meeting later this year (likely ASH), we believe these data could support a 2021 FDA approval and help spur uptake at transplant centers.” He added, “We believe omidubicel has been de-risked with the successful Phase 3 results.”

Adding to the good news, Breidenbach argues that the results show omidubicel is “competitive with more widely used grafts, including matched unrelated donor (MUD) and mismatched-related donor grafts.” He noted, “As such, these data may support wider adoption of omidubicel among transplant physicans, although longer follow-up will be required to assess relapse rates and treatment-related mortality.”

Based on all of the above, Breidenbach keep an Outperform (i.e. Buy) rating on the stock. Along with his bullish call, he also bumped up the price target from $18 to $20. This implies upside potential of a massive 352%. (To watch Breidenbach’s track record, click here)    

Turning now to the rest of the Street, other analysts are on the same page. Only Buy ratings have been received in the last three months, 3, in fact, so the consensus rating is a Strong Buy. In addition, the $18 average price target puts the upside potential at 307%. (See Gamida Cell stock analysis on TipRanks)

VBI Vaccines (VBIV)

Using its enveloped virus-like particle (eVLP) platform, VBI Vaccines develops vaccines that could be capable of addressing unmet needs in infectious disease and immuno-oncology. With one analyst, Canaccord Genuity’s John Newman, expecting a “catalyst-rich” second half of the year for the company, its $2.49 share price could mean that now is the time to pull the trigger.

The five-star analyst tells investors the fourth quarter of 2020 will see VBIV submit regulatory approval filings for Sci-B-Vac, its vaccine against hepatitis B. These will be comprised of data from the CONSTANT and PROTECT Phase 3 trials in the U.S., Europe and Canada. “We continue to expect the agencies will view Sci-B-Vac's regulatory applications favorably and expect approvals in 2021...We continue to believe a key factor for VBIV will be whether the Advisory Committee on Immunization Practices (ACIP) recommends Sci-B-Vac at a two-dose immunization schedule, for their commercial launch,” he commented.

As for its chronic hepatitis B virus (HBV) therapy, VBI-2601, initial human proof-of-concept data from the Phase 1b/2a study could be published in the second half of this year as well.

Looking at its VBI-1901 asset, which was designed for use in recurrent Glioblastoma Multiforme (rGBM) patients, expanded immunologic, tumor and clinical data from the GM-CSF arm and initial immunologic and tumor response data from the AS01B arm are slated for release mid-year and in Q4, respectively. “We look for continued positive data for VBI-1901 in GBM,” Newman said.

If that wasn’t enough, a pan-coronavirus vaccine is in the works, with VBIV expecting IND-enabling animal testing for the candidate, VBI-2901, to start in the second quarter. On top of this, the company could have clinical candidates selected and enough clinical supply ready in Q4 2020.

As VBIV’s operations through 2021 will most likely be supported by the $57.5 million equity raise last month and its $35.8 million in cash as of Q1 2020, it’s no wonder Newman is optimistic. In addition to maintaining a Buy recommendation, he did trim the price target by $1 to account for share dilution. That being said, the $3 figure still leaves room for a possible twelve-month gain of 20%. (To watch Newman’s track record, click here)

Do other analysts agree with Newman? As it turns out, they do. With 100% Street support, or 3 Buy ratings to be exact, the consensus is unanimous: VBIV is a Strong Buy. At $4.33, the average price target is more aggressive and suggests 74% upside potential. (See VBI Vaccines stock analysis on TipRanks)

Cyclacel Pharmaceuticals (CYCC)

The last biotech on our list, Cyclacel Pharmaceuticals, uses cell cycle, transcriptional regulation and DNA damage response biology to develop cancer therapies. Currently going for $4.59 apiece, some members of the Street are telling investors to get onboard before shares take off on an upward trajectory.

Writing for Roth Capital, analyst Jonathan Aschoff believes the strength of CYCC’s development program makes it a stand-out. The company is focused on solid tumors, with it conducting its clinical trials so that it can still report updated fadraciclib Phase 1 data with the higher frequency IV dosing schedule in advanced solid tumors, initial Phase 1 safety and PK results with oral fadraciclib as well as kick off its Phase 1/2 precision medicine trial in early 2021. It should be noted that oral fadraciclib has already demonstrated concordance with IV pharmacokinetics based on early clinical data.

With this strong technology, Aschoff argues that CYCC is targeting the unmet need in the cyclin E overexpressing tumors of the breast, endometrium/uterus and ovaries space. “The solid tumor program is key to our CYCC valuation, as projected revenue from this cyclin E overexpressing population represents more than 70% of projected revenue. We note that cyclin E is overexpressed in one-third of HR+ breast cancer patients resistant to first-line therapy, where patients could receive fadraciclib alone or potentially in combination with hormonal therapy. This population, combined with resistant second-line ovarian and endometrial/uterine cancer patients with high cyclin E amount to just over 100,000 patients in the U.S.,” he explained.

Additionally, CYCC is set to publish initial Phase 1 fadraciclib/ venetoclax results in rel/ref AML/MDS and CLL, initial Phase 1 sapacitabine/venetoclax results in rel/ref AML/MDS and initial Phase 1 CYC140 data in advanced leukemias. While Phase 1b/2 sapacitabine/olaparib results in BRCA mutant metastatic breast cancer are also expected, the timing is uncertain.

Some investors have expressed concern regarding COVID-19's impact on the company’s trials, but Aschoff points out that thus far, CYCC hasn’t experienced any enrollment delays. He added, “CYCC recently announced its intent to study the potential of fadraciclib to be an early inhibitor of the detrimental inflammatory response observed in COVID-19 patients, specifically to induce MCL1 downregulation and apoptosis of inflammatory neutrophils.”

Consider all of this combined with its $27.3 million cash position that will support its development programs through 2022, and it makes sense why Aschoff remains squarely in the bull camp. To this end, he reiterated a Buy rating and $24 price target, indicating 423% upside potential. (To watch Aschoff’s track record, click here)

Like Aschoff, other analysts also take a bullish approach. CYCC’s Strong Buy consensus rating breaks down into 3 Buys and zero Holds or Sells. Given the $16.33 average price target, shares could soar 256% in the next year. (See Cyclacel stock analysis on TipRanks)

To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

The post 3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential appeared first on TipRanks Financial Blog.

Read More

Continue Reading

Government

Gaslighting: The American People Are Trapped In A Textbook Abusive Relationship

Gaslighting: The American People Are Trapped In A Textbook Abusive Relationship

Authored by Daisy Luther via The Organic Prepper blog,

Imagine…

Published

on

Gaslighting: The American People Are Trapped In A Textbook Abusive Relationship

Authored by Daisy Luther via The Organic Prepper blog,

Imagine this.

A woman, for the sake of my story, is in a marriage with a partner who does not respect her. He insults her regularly, belittles her efforts to improve herself or her situation, and minimizes her feelings.

In fact, when she tries to stand up for herself, things get even worse. The partner calls into question her memories of the event. He dismisses the way things made her feel, calling the emotions “ridiculous” or “stupid.” He convinces her she’s overreacting and that he was only trying to do what was best for her. When she brings something up, he completely rewrites the event, causing her to doubt what actually happened because she’s in a vulnerable state due to the constant abuse.

In a situation like this, the abused partner often feels powerless, confused, and unable to leave the situation. They are at a disadvantage because they’ve been influenced to doubt their own reality. This leaves them trapped deeper and deeper in the abusive scenario. They feel unable to escape because they’re really not sure what actually happened. Were they blowing things out of proportion? Are they, in fact, stupid, forgetful, and inept?

Abusive relationships follow a pattern. There’s a period of breaking the victim down, isolating them from their support systems, and making them dependent on the abuser. Then, the abused partner is maneuvered into the belief that she can’t get by on her own.

This master manipulation is how people become trapped in abusive relationships.

And, as I’m about to show, not all abusive relationships are one-on-one romantic relationships.

What is gaslighting?

Medical News Today defines gaslighting.

Gaslighting is a form of psychological abuse in which a person or group causes someone to question their own sanity, memories, or perception of reality. People who experience gaslighting may feel confused, anxious, or as though they cannot trust themselves.

The term “gaslighting” comes from the 1944 classic film (and before that, the play), Gaslight. In the story, a husband tries to make his wife believe she is suffering from a mental illness. Starring Ingrid Bergman and Charles Boyer, it’s well worth a watch.

Gaslighting is a form of narcissistic abuse. For a quick refresher on the definition of a narcissist and the techniques they use, go here.

Forbes offers the following signs you are being gaslit:

Signs to watch for include:

The “Twilight Zone” effect. Victims of gaslighting often report feeling like a situation is surreal—like it’s happening on a different plane from the rest of their life.

Language describing you or your behavior as crazy, irrational or overemotional. “When I asked women about their partners’ abusive tactics, they often described being called a ‘crazy bitch,’” Sweet writes in “The Sociology of Gaslighting” in American Sociological Review. “This phrase came up so frequently, I began to think of it as the literal discourse of gaslighting.”

Being told you’re exaggerating.

Feeling confused and powerless after leaving an interaction.

Isolation. Many gaslighters make efforts to isolate victims from friends, family and other support networks.

Tone policing. A gaslighter may criticize your tone of voice if you challenge them on something. This is a tactic used to flip the script and make you feel that you’re the one to blame, rather than your abuser.

A cycle of warm-cold behavior. To throw a victim off balance, a gaslighter may alternate between verbal abuse and praise, often even in the same conversation.

Gaslighting is a deliberate attempt to provoke self-doubt, confusion, and dependence.

How does someone gaslight another person?

Again, let’s look to the experts. Medical News Today provides these examples of how gaslighting might take place:

  • Countering: This is when someone questions a person’s memory. They may say things such as, “Are you sure about that? You have a bad memory,” or “I think you are forgetting what really happened.”
  • Withholding: This involves someone pretending they do not understand the conversation, or refusing to listen, to make a person doubt themselves. For example, they might say, “Now you are just confusing me,” or “I do not know what you are talking about.”
  • Trivializing: This occurs when a person belittles or disregards how someone else feels. They may accuse them of being “too sensitive” or overreacting in response to valid and reasonable concerns.
  • Denial: Denial involves a person refusing to take responsibility for their actions. They may do this by pretending to forget what happened, saying they did not do it, or blaming their behavior on someone else.
  • Diverting: With this technique, a person changes the focus of a discussion by questioning the other person’s credibility. For example, they might say, “That is just nonsense you read on the internet. It is not real.”
  • Stereotyping: An article in the American Sociological Review says that a person may intentionally use negative stereotypes about someone’s gender, race, ethnicity, sexuality, nationality, or age to gaslight them. For example, they may say that no one will believe a woman if she reports abuse.

After a period of time, this emotional barrage results in the target of the gaslighting suffering from confusion, doubt, and self-blame.

  • feeling uncertain of their perceptions
  • frequently questioning if they are remembering things correctly
  • believing they are irrational or “crazy”
  • feeling incompetent, unconfident, or worthless
  • constantly apologizing to the abusive person
  • defending the abusive person’s behavior to others
  • becoming withdrawn or isolated from others

The Forbes article offered these specific examples of gaslighting in romantic relationships.

“Ebony’s partner would steal her money and then tell her she was ‘careless’ about finances and had lost it herself.”

“Adriana’s boyfriend hid her phone and then told her she had lost it, in a dual effort to confuse her and prevent her from communicating with others.”

“Jenn described her ex-boyfriend as a ‘chameleon’ who made up small stories to confuse her, like lying about what color shirt he had worn the day before to make her feel disoriented.”

“Emily described her ex-husband stealing her keys so she could not leave the house and then insisting she had lost them ‘again.’”

But if you think this phenomenon is limited to women being abused by their husbands or boyfriends, you’d be wrong.

Gaslighting doesn’t just happen in romantic relationships.

Gaslighting is a complicated thing. While it’s common in abusive romantic relationships, it can also occur in unhealthy parent-child relationships, sibling relationships, or even workplaces. But that’s not all. It can also occur on a much broader scale.

Racial gaslighting

According to an article in Politics, Group, and Identities, racial gaslighting is when people apply gaslighting techniques to an entire racial or ethnic group in order to discredit them. For example, a person or institution may say that an activist campaigning for change is irrational or “crazy.”

Political gaslighting

Political gaslighting occurs when a political group or figure lies or manipulates information to control people, according to an article in the Buffalo Law Review.

For example, the person or political party may downplay things their administration has done, discredit their opponents, imply that critics are mentally unstable, or use controversy to deflect attention away from their mistakes.

Institutional gaslighting

Institutional gaslighting occurs within a company, organization, or institution, such as a hospital. For example, they may portray whistleblowers who report problems as irrational or incompetent, or deceive employees about their rights.

This often occurs to cover up a mistake that could result in the person who erred facing punitive consequences or to keep people “in their place.” It’s a control mechanism, pure and simple.

Have we been gaslit by our own government?

I don’t think it’s farfetched to say that we, the people of the United States of America, have been gaslit.

Does this sound familiar? Lockdowns that keep you away from friends and loved ones? Losing your income and becoming dependent on handouts doled out by the government? Being censored and mocked when you say anything that is not in line with the official narrative? Being treated like a crazy conspiracy theorist who should be punished because of the harm you’re causing to others if you refuse to go along?

When you look at it this way, it feels like the entire US government and media have colluded to abuse the people. Many of the Covid-related “truths” that were promoted by the government and the media that we were not allowed to dispute have now been proven to be false. Stories we couldn’t question about the origins of the pandemic have been proven false. In another incident of broad-scale gaslighting unrelated to the pandemic, a lot of evidence has been produced that shows the Biden family may have received money from influence-peddling, but the media tells us not to believe it.

And like good little victims, it seems like a hefty portion of the country is refusing to believe the evidence, instead believing in the good intentions of their abusers. They’ve been gaslit, brainwashed, and are unable to break free of the manipulation.

And it’s still going on.

Recently Supreme Court Justice Neil Gorsuch wrote a scathing opinion of the US government’s handling of the Covid pandemic, saying that we “have experienced the greatest intrusions on civil liberties in the peacetime history of this country.”

“Executive officials across the country issued emergency decrees on a breathtaking scale. Governors and local leaders imposed lockdown orders forcing people to remain in their homes. They shuttered businesses and schools, public and private. They closed churches even as they allowed casinos and other favored businesses to carry on. They threatened violators not just with civil penalties but with criminal sanctions too. They surveilled church parking lots, recorded license plates, and issued notices warning that attendance at even outdoor services satisfying all state social-distancing and hygiene requirements could amount to criminal conduct. They divided cities and neighborhoods into color-coded zones, forced individuals to fight for their freedoms in court on emergency timetables, and then changed their color-coded schemes when defeat in court seemed imminent,” he said.

At the federal level, he highlighted not only immigration decrees but vaccine mandates, the regulation of landlord-tenant relations and pressure on social media companies to suppress “misinformation.”

The gaslighting blowback was immediate, with breathlessly outraged headlines.

Slate eloquently opined, “Neil Gorsuch’s List of “Civil Liberties Intrusions” Is, Uh, Missing a Few Things.” making sure to throw plenty of insulting talking points into their introductory paragraph in their attempt to liken a Supreme Court Justice who was educated at Harvard Law, Oxford, Georgetown, and Columbia, to an ignorant relative one merely tolerates. And they insinuated he was a racist.

Gorsuch has long railed against such policies, and his opinions have taken on an increasingly shrill tone, like the Fox News–poisoned uncle who hectors you about the plandemic in 3,000-word Facebook comments. The justice’s rant in Arizona v. Mayorkas, however, hits a new low, moving beyond the usual yada-yada grievance parade to issue a thesis statement of sorts…

…As Vox’s Ian Millhiser quickly pointed out, this sweeping claim leaves out two “intrusions on civil liberties” that any person with a basic grasp of history and sanity would surely rank as worse than pandemic policies: slavery and Jim Crow.

An opinion piece published in the NY Times gasped, “Neil Gorsuch Has Given Himself Away,” made it seem as if the Justice was belittling every other civil rights mishap in the history of America while also blithely disregarding the folks who died during the pandemic.

The New Republic condescendingly liberal-splained to the rest of us “What Neil Gorsuch Got Wrong About the Pandemic,” stating that “The justice’s vision of the judiciary’s role in public health may be more dangerous than any Covid-era restriction.”

The site Above The Law literally said Gorsuch was stupid in the piece, “For An Originalist, Gorsuch Is Clearly Slacking On His Definitions And Their Historical Meanings.” The subheading reads, “Is what he said stupid? Yes. But let’s be technical here.”

Law and Crime website also played the race card and did so right in the headline: Neil Gorsuch implies COVID restrictions were worse than slavery and Jim Crow, and the internet noticed.

Let’s look at that definition of political gaslighting again…

For example, the person or political party may downplay things their administration has done, discredit their opponents, imply that critics are mentally unstable, or use controversy to deflect attention away from their mistakes.

Oof. If that textbook case of gaslighting isn’t embarrassing, it should be.  Then again, narcissists are rarely embarrassed.

The gaslighting will escalate.

Another thing about narcissists: they just get angry when they’re called out. They will respond by gaslighting you harder or seeking to “ruin” you. (source) They’ll punish you with a loss of “privileges,” money, material goods, and freedom. We’ve watched it happen again and again in our cancel culture media. Some of us have been unfortunate enough to have personal relationships with narcissists and learned this the hard way.

The only way to end narcissistic abuse and gaslighting is to recognize it and remove yourself from the situation as much as you can. Obviously, when it’s our entire government and society, that becomes complicated. You may be stuck with just recognizing it. But that in itself gives you a certain amount of freedom and personal power. It helps you get off the hamster wheel, and you begin to spot the manipulations more easily.

One thing we can be sure of is that this will escalate as more and more people say, “No, that’s not what happened.” This is something we can expect, and in some small way, maybe we can take comfort in the response. Perhaps we can smile to ourselves because we know those who were trying to manipulate us all are on the defensive.

Tyler Durden Mon, 05/29/2023 - 18:20

Read More

Continue Reading

Government

The Great Silence

The Great Silence

Authored by Jeffrey Tucker via DailyReckoning.com,

The kids are two years behind in education. Inflation still rages. White-collar…

Published

on

The Great Silence

Authored by Jeffrey Tucker via DailyReckoning.com,

The kids are two years behind in education. Inflation still rages. White-collar jobs are disappearing thanks to the reversal of Fed policy. Household finances are a wreck. The medical industry is in upheaval. Trust in government has never been lower.

Major media too is discredited. Young people are dying at levels never seen. Populations are still on the move from lockdown states to where it is less likely. Surveillance is everywhere, and so is political persecution. Public health is in a disastrous state, with substance abuse and obesity all at new records.

Each one of these, and many more besides, are continued fallout from the pandemic response that began in March 2020. And yet here we are 38 months later and we still don’t have honesty or truth about the experience.

Officials have resigned, politicians have tumbled out of office and lifetime civil servants have departed their posts, but they don’t cite the great disaster as the excuse. There is always some other reason.

This is the period of the great silence. We’ve all noticed it. The stories in the press recounting all the above are conventionally scrupulous about naming the pandemic response much less naming the individuals responsible.

Maybe there is a Freudian explanation: things so obviously terrible and in such recent memory are too painful to mentally process, so we just pretend it didn’t happen. Plenty in power like this solution.

Everyone in a position of influence knows the rules. Don’t talk about the lockdowns. Don’t talk about the mask mandates. Don’t talk about the vaccine mandates that proved useless and damaging and led to millions of professional upheavals.

Don’t talk about the economics of it. Don’t talk about collateral damage. When the topic comes up, just say, “We did the best we could with the knowledge we had,” even if that is an obvious lie.

Above all, don’t seek justice.

Where’s the National Commission?

There is this document intended to be the “Warren Commission” of COVID slapped together by the old gangsters who advocated for lockdowns. It is called Lessons from the Covid War: An Investigative Report.

The authors are people like Michael Callahan (Massachusetts General Hospital), Gary Edson (former deputy national security adviser), Richard Hatchett (Coalition for Epidemic Preparedness Innovations), Marc Lipsitch (Harvard University), Carter Mecher (Veterans Affairs), and Rajeev Venkayya (former Gates Foundation and now Aerium Therapeutics).

If you have been following this disaster, you might know at least some of the names. Years before 2020, they were pushing lockdowns as the solution for infectious disease. Some claim credit for having invented pandemic planning. The years 2020–2022 were their experiment.

As it was ongoing, they became media stars, pushing compliance, condemning as disinformation and misinformation anyone who disagreed with them. They were at the heart of the coup d’etat, as engineers or champions of it, that replaced representative democracy with quasi-martial law run by the administrative state.

The first sentence of the report is a complaint:

We were supposed to lay the groundwork for a National COVID Commission. The COVID Crisis Group formed at the beginning of 2021, one year into the pandemic. We thought the U.S. government would soon create or facilitate a commission to study the biggest global crisis so far in the 21st century. It has not.

That is true. There is no National COVID Commission. You know why? Because they could never get away with it, not with legions of experts and passionate citizens who wouldn’t tolerate a coverup.

The public anger is too intense. Lawmakers would be flooded with emails, phone calls and daily expressions of disgust. It would be a disaster. An honest commission would demand answers that the ruling class is not prepared to give. An “official commission” perpetuating a bunch of baloney would be dead on arrival.

This by itself is a huge victory and a tribute to indefatigable critics.

‘We Didn’t Crack Down Hard Enough’

Instead, the “COVID Crisis Group” met with funding from the Rockefeller and Charles Koch foundations and slapped together this report. Despite being celebrated as definitive by The New York Times and The Washington Post, it has mostly had no impact at all.

It is far from obtaining the status of being some kind of canonical assessment. It reads like they were on deadline, fed up, typed lots of words and called it a day.

Of course it is whitewash.

It begins with a bang to denounce the U.S. policy response: “Our institutions did not meet the moment. They did not have adequate practical strategies or capabilities to prevent, to warn, to defend their communities or fight back in a coordinated way, in the United States and globally.”

Mistakes were made, as they say.

Of course the upshot of this kvetching is not to criticize what Justice Neil Gorsuch calls “the greatest intrusions on civil liberties in the peacetime history of this country.” They hardly mention those at all.

Instead they conclude that the U.S. should have surveilled more, locked down sooner (“We believe that on Jan. 28 the U.S. government should have started mobilizing for a possible COVID war”), directed more funds to this agency rather than that and centralized the response so that rogue states like South Dakota and Florida could not evade centralized authoritarian diktats next time.

The authors propose a series of lessons that are anodyne, bloodless and carefully crafted to be more-or-less true but ultimately structured to minimize the sheer radicalism and destructiveness of what they favored and did. The lessons are clichés such as we need “not just goals but road maps,” and next time we need more “situation awareness.”

There is no new information in the book that I could find, unless something is hidden therein that escaped my notice. It’s more interesting for what it does not say. Some words that never appear in the text: Sweden, ivermectin, ventilators, remdesivir and myocarditis.

‘Look, Lockdowns and Mandates Worked!’

Perhaps this gives you a sense of the book and its mission. And on matters of the lockdowns, readers are forced to endure claims such as “all of New England — Massachusetts, the city of Boston, Connecticut, Rhode Island, New Hampshire, Vermont, and Maine — seem to us to have done relatively well, including their ad hoc crisis management setups.”

Oh really! Boston destroyed thousands of small businesses and imposed vaccine passports, closed churches, persecuted people for holding house parties, and imposed travel restrictions. There is a reason why the authors don’t elaborate on such preposterous claims. They are simply unsustainable.

One amusing feature seems to me to be a foreshadowing of what is coming. They throw Anthony Fauci under the bus with sniffy dismissals: “Fauci was vulnerable to some attacks because he tried to cover the waterfront in briefing the press and public, stretching beyond his core expertise—and sometimes it showed.”

Ooooh, burn!

“Trump Was a Comorbidity”

This is very likely the future. At some point, Fauci will be scapegoated for the whole disaster. He will be assigned to take the fall for what is really the failure of the national security arm of the administrative bureaucracy, which in fact took charge of all rule-making from March 13, 2020, onward, along with their intellectual cheerleaders. The public health people were just there to provide cover.

Curious about the political bias of the book? It is summed up in this passing statement: “Trump was a comorbidity.”

Oh how highbrow! How clever! No political bias here!

Maybe this book by the Covid Crisis Group hopes to be the last word. This will never happen. We are only at the beginning of this. As the economic, social, cultural, and political problems mount, it will become impossible to ignore the incredibly obvious.

The masters of lockdowns are influential and well-connected but not even they can invent their own reality.

Tyler Durden Mon, 05/29/2023 - 16:00

Read More

Continue Reading

Spread & Containment

Kids missing school: Why it’s happening — and how to stop it

About 10 million US children are chronically absent from school.

Published

on

By

Students who miss a lot of school are more likely to drop out. maroke/iStock via Getty Images Plus

Chronic absenteeism – defined as a student’s missing approximately 18 days of the school year – is on the rise. Compared with the years preceding the COVID-19 pandemic, almost three-quarters of U.S. public schools are now showing significant increases.

SciLine interviewed Dr. Joshua Childs, assistant professor of educational leadership and policy at the University of Texas at Austin, who shared his thoughts on why students become chronically absent, the academic and social losses they incur by missing school, and the strategies available to boost student attendance, including the relationship between absenteeism and school athletics.

Dr. Joshua Childs discusses chronic absenteeism.

Below are some highlights from the discussion. Answers have been edited for brevity and clarity.

What is chronic absenteeism?

Joshua Childs: Chronic absenteeism is missing 10% or more of the school year for any reason. That includes excused absences, like a doctor’s visit or a class field trip, and unexcused absences, such as skipping or being truant from school, and being expelled or suspended from school for behavioral reasons.

How common is chronic absenteeism?

Joshua Childs: On average, around 7.5 million to 8 million students are chronically absent each year. That’s a significant number of students who are missing school for a variety of reasons.

But since the start of the pandemic in March of 2020, the latest national data from the U.S. Department of Education has shown that the number has increased to around 10 million students being identified as chronically absent from school.

How does missing lots of school affect kids?

Joshua Childs: Academically, we know that students who are chronically absent are more likely to drop out and less likely to graduate from high school.

Socially, for students who are chronically absent, they tend to feel less connected to the school and the overall school environment or community, less likely to build connections with the adults or educators within the school building, and also least likely to build connections with their peers.

Developmentally, we know that students who are chronically absent tend to fall behind academically from their peers, and tend to be behind when it comes to math and reading or language arts testing outcomes.

What barriers keep kids out of school?

Joshua Childs: When it comes to physical health, we know that asthma followed by obesity and dental issues are the leading cause for students to miss school. And so not having adequate access to health care to be able to address some of those physical ailments can lead to students’ missing school consistently.

Mental health issues and concerns, particularly or specifically since the pandemic, have increased for students and can lead to their missing school.

Next: the neighborhood context. Are there safe routes, safe transportation, adequate busing options for students to attend school? And attend school not only every day, but on time?

Then there’s the overall school environment. Is it welcoming and engaging for students? Is the school environment physically safe – not only in terms of interactions with peers and the adults, but are there issues with asbestos, or having adequate and reliable desks and textbooks and safe infrastructure within the school building? If not, that can lead to chronic absenteeism rates increasing.

And finally … the family. Do families feel connected and a part of the school environment? Is there constant communication about the importance of attending school and being engaged with the overall school community? Do families understand the value of what the school environment can do for their child, and how consistently showing up can lead to outcomes that are beneficial?

What’s the link between attendance and sports?

Joshua Childs: In many states, coaches have to be full-time employees of the district in which they’re coaching. And so many times coaches are teachers, whether it’s in science, history, math or reading. So they spend significant hours of the school day with students, and also before and after school and weekends over the summer due to the different types of sports that students could be involved in.

One of the most important aspects when it comes to improving student attendance is a connection that students make with adults, particularly those adults engaged with them on a daily basis. And so there’s a role for the coaches to play.

Watch the full interview to hear about how to reduce chronic absenteeism in schools.

SciLine is a free service based at the nonprofit American Association for the Advancement of Science that helps journalists include scientific evidence and experts in their news stories.

Joshua Childs does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Trending